QuantLogix ← CAH scorecard
📅 CAH Earnings Preview
Cardinal Health, Inc.
Next report (est.)
08/04/2026
Countdown
Imminent
EPS growth YoY
+0.0%
Revenue growth YoY
+18.8%
Options-implied earnings move
±2.3%
The at-the-money straddle prices a move to roughly $254.20 or $242.80 from $248.50 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
02/05/2026 ±3.0% +9.8% under-priced
10/30/2025 ±1.7% +15.4% under-priced
08/12/2025 ±2.3% -7.2% under-priced
05/01/2025 ±2.0% +3.0% under-priced
01/30/2025 ±1.7% +0.4% over-priced
11/01/2024 ±1.8% +7.0% under-priced
08/14/2024 ±2.5% +3.7% under-priced
05/02/2024 ±1.4% +0.8% over-priced
Across these reports, options implied an average ±2.1% move vs an actual average of 5.9% — the stock stayed inside the implied band 25% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 — $65.6B $467M
Q1 FY2026 $1.88 $64.0B $450M
Q4 FY2025 — $60.2B $239M
Q3 FY2025 — $54.9B $506M
Analyst posture
Buy / Strong Buy
20
Hold
3
Sell
0
Stable: -1 net change 30d
Live 5-factor engine read: Buy · 60/100 Full scorecard →
Get alerted before every CAH report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CAH before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Cardinal Health, Inc. (CAH) reports imminently, with the next report estimated for 08/04/2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 5.9% on average — the market has tended to under-price CAH's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 18.8%. QuantLogix's live 5-factor engine currently reads CAH as a buy at 60/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →